NovoPen Echo® Plus Blue

NovoPen® Echo Plus Blue is a reusable smart insulin pen designed by Novo Nordisk to support precise, reliable insulin self-administration for people with diabetes who require injectable insulin therapy. This device uses 3 ml Penfill® cartridges of Novo Nordisk insulin and provides half-unit (0.5 unit) dosing increments, enabling tailored dosing for both basal and bolus insulin needs.

Unlike traditional reusable pens, the Echo Plus model includes dose memory functionality, recording the time, date and amount of insulin injected for up to several months of data. Using Near Field Communication (NFC) and compatible mobile apps, you can transfer this dosing history to your smartphone or other devices, helping you and your healthcare provider review insulin use alongside glucose data to support personalised diabetes management.

Brand: Novo Nordisk — NovoPen® Echo Plus (Red).

Device Type: Reusable smart insulin pen designed for insulin delivery.

Compatibility: Intended for use with Novo Nordisk Penfill® 3 ml insulin cartridges and NovoFine® single-use disposable needles (sold separately).

Important: NovoPen® Echo Plus Red is a medical device. Only use after training by a qualified healthcare professional. Always refer to the official user guide and the Patient Information Leaflet supplied with your insulin and device.

Preparation:

1. Insert an insulin cartridge (Penfill® 3 ml).
2. Attach a new sterile needle. Ensure insulin type matches your prescription.
3. Perform a flow check (prime) to ensure insulin is ready to deliver.

Selecting and Injecting Dose:

1. Turn the dose dial to select the prescribed units (up to 30 units in 0.5-unit steps).
2. Clean the injection site as recommended (e.g., with alcohol swab).
3. Insert the needle into the skin and press the dose button fully to deliver insulin.
4. Hold for a few seconds and then remove and safely dispose of the needle in an approved sharps container.

Dose Memory and Data Transfer:

• After injection, the dose memory display records the dose, time and date of injections.
• Use NFC-capable apps to transfer and review insulin data alongside glucose readings, helping to support personalised care planning. 

As a medical device rather than a medicinal product, NovoPen® Echo Plus Red does not contain pharmacological ingredients. Instead, its components are designed to facilitate accurate and safe insulin delivery:

• Pen body and cap – durable medical-grade plastics.

• Dose dial and internal mechanisms – for precise, incremental dosing (0.5 unit steps).

• Memory module – records dosing data.

• NFC transmitter – for data transfer to compatible apps.

• Internal mechanics – engineered components ensuring consistent insulin delivery.

Insulin supply: Insulin itself is contained in Novo Nordisk Penfill® cartridges which you must obtain separately and use with this pen. Always follow the insulin product leaflet for active ingredient and formulation information.

Safety & Warnings

NovoPen® Echo Plus Red is a diabetes treatment device used for subcutaneous insulin injections. It should only be used by the person it was prescribed for after appropriate training by a healthcare professional.

Important precautions:

• Do not share the pen, cartridges or needles with others.

• Always use a new sterile needle for each injection.

• Ensure you have the correct insulin type and dose loaded before each injection.

• Do not leave the pen in extremes of temperature (e.g., in a car on a hot/cold day).

• If the pen is dropped or damaged, consult a healthcare professional before further use.

Potential Issues & Reporting

• Incorrect dose delivery: If the pen is not primed correctly or air bubbles are present, the full insulin dose may not be delivered, potentially leading to hyperglycaemia or hypoglycaemia. Follow instructions carefully.

• Allergic or injection site reactions: Although uncommon, watch for local irritation. If persistent, seek advice.

• Training required: This device should not be used without proper instruction. Do not use if you do not fully understand how to operate it.

• Report device issues: In the UK, side effects or device faults can be reported through the MHRA Yellow Card Scheme or to Novo Nordisk customer services.